20.04Open20.04Pre Close0 Volume0 Open Interest82.50Strike Price0.00Turnover0.00%IV-27.68%PremiumOct 18, 2024Expiry Date33.58Intrinsic Value100Multiplier-2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.45Leverage Ratio--Theta--Rho--Eff Leverage--Vega
CRISPR Therapeutics Stock Discussion
Most of Wallstreet and retail investors don't understand Crispr and most see it as a very risky stock to invest in but once it begins rolling out its cures and making obscene amounts of cash..Along with license agreements to other companies Crispr Theraputics share price will rise significantly. ...
$ONEOK Inc (OKE.US)$ : “I think Oneok is terrific. I would indeed buy more.”
$DexCom (DXCM.US)$ : “Dexcom had a real bad miss. They still really haven’t fully explained why that is...I’d stay away from De...
$CRISPR Therapeutics (CRSP.US)$
$Moderna (MRNA.US)$
• Editing Genes | $CRISPR Therapeutics (CRSP.US)$ , $Intellia Therapeutics (NTLA.US)$ , $Beam Therapeutics (BEAM.US)$ , $Verve Therapeutics (VERV.US)$ , $Editas Medicine (EDIT.US)$
• Creating Therapies | $Prime Medicine (PRME.US)$ , $Sana Biotechnology (SANA.US)$
• Building DNA | $Twist Bioscience (TWST.US)$ , $Ginkgo Bioworks (DNA.US)$ , $Pacific Biosciences of California (PACB.US)$ , $Illumina (ILMN.US)$
• Dis...
No comment yet